N/A(healthy adults)
Conditions
Interventions
Single intake of a test food 1
Single intake of a test food 2
Single intake of a test food 3
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Japanese males aged 20-30 years 2)Individuals whose written informed consent has been obtained 3)Individulals who can visit an inspection facility and collect multiple blood samples (6 times/1 day x 3 observations) in designated days 4)Healthy subjects * Individulals who does not have serious organ damage or disease, is not receiving any related treatment, or is not receiving any type of medication 5)Subjects with a BMI 20-24.9
Exclusion criteria
Exclusion criteria: 1)Individuals with chronic diseases or disorders of the liver, biliary tract, digestive system, circulatory system, respiratory system, kidney, urinary system, mental, neurological system, or blood system 2)Individuals who smoke 3)Individuals who may change their lifestyle during the study period (Night shifts, long trips, etc.) 4)Individuals who do not like to consume highly sweet foods, sweets, or beverages 5)Individuals whose lifestyle is irregular such as always working at night 6)Individuals who attend hospital, take medication, or receive treatment * Individuals who are receiving treatment or medication for diabetes 7)Individuals who have or have been diagnosed with lifestyle-related diseases such as individuals whose fasting blood glucose level is in the diabetic range 8)Individuals who have severe anemia 9)Individuals who have taken medication for the treatment of disease in the past 1 month (Excluding headaches, menstrual cramps, and colds) 10)Individuals who were hospitalized and received treatment in the past 6 months 11)Individuals who drink a lot of alcohol (60 g or more of alcohol per day) 12)Individuals who are participating in other clinical trial, are scheduled to participate in other clinical trial within 4 weeks after completion of the trial, or after consent to participate in the trial 13)Individuals who are allergic to medicines or foods
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose Metabolism | — |
Countries
Japan
Contacts
Public ContactMariko Yoshikawa
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed